Wenqing Liang

Dr. Wenqing Liang

Medical Research Center, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan 316000, Zhejiang Province, China
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
HDHaigang Ding
Haigang Ding
JZJuan Zhang
Juan Zhang
FZFeng Zhang
Feng Zhang
SZSongou Zhang
Songou Zhang
XCXiaozhen Chen
Xiaozhen Chen
QXQiong Xie
Qiong Xie
PCOS has a wide range of negative impacts on women’s health and is one of the most frequent reproductive systemic endocrine disorders. PCOS has complex characteristics and symptom heterogeneity due to the several pathways that are involved in the infection and the absence of a comm14on cause. A recent study has shown that the main etiology and endocrine aspects of PCOS are the increased level of androgen, which is also known as “hyperandrogenemia (HA)” and secondly the “insulin resistance (IR)”. The major underlying cause of the polycystic ovary is these two IR and HA, by initiating the disease and its severity or duration. As a consequence, study on Pathogenesis is crucial to understand the effect of “HA” and “IR” on the pathophysiology of numerous symptoms linked to PCOS. A deep understanding of the pattern of the growth in PCOS for HA and IR can help ameliorate the condition, along with adjustments in nutrition and life, as well as the discovery of new medicinal products. However, further research is required to clarify the mutual role of IR and HA on PCOS development.

20 January 2021 in Cellular & Molecular Biology Letters
Verified
Journal Article
Open access
PDF file
WLWenqing Liang
Wenqing Liang
XCXiaozhen Chen
Xiaozhen Chen
SZSongou Zhang
Songou Zhang
JFJian Fang
Jian Fang
MCMeikai Chen
Meikai Chen
XCXuerong Chen
Xuerong Chen
Mesenchymal stem cells (MSCs) show homing capacity towards tumor sites. Numerous reports indicate that they are involved in multiple tumor-promoting processes through several mechanisms, including immunosuppression; stimulation of angiogenesis; transition to cancer-associated fibroblasts; inhibition of cancer cell apoptosis; induction of epithelial–mesenchymal transition (EMT); and increase metastasis and chemoresistance. However, other studies have shown that MSCs suppress tumor growth by suppressing angiogenesis, incrementing inflammatory infiltration, apoptosis and cell cycle arrest, and inhibiting the AKT and Wnt signaling pathways. In this review, we discuss the supportive and suppressive impacts of MSCs on tumor progression and metastasis. We also discuss MSC-based therapeutic strategies for cancer based on their potential for homing to tumor sites.

1 May 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YDYongqiang Dong
Yongqiang Dong
XWXudong Wu
Xudong Wu
XCXuerong Chen
Xuerong Chen
PZPing Zhou
Ping Zhou
FXFangming Xu
Fangming Xu
WLWenqing Liang
Wenqing Liang
Currently, stem cell nanotechnology is one of the novel and exciting fields. Certain experimental studies conducted on the interaction of stem cells with nanostructures or nanomaterials have made significant progress. The significance of nanostructures, nanotechnology, and nanomaterials in the development of stem cell-based therapies for degenerative diseases and injuries has been well established. Specifically, the structure and properties of nanomaterials affecting the propagation and differentiation of stem cells have become a new interdisciplinary frontier in material science and regeneration medicines. In the current review, we highlight the recent major progress in this field, explore the application prospects, and discuss the issues, approaches, and challenges, to improve the applications of nanotechnology in the research and development of stem cells.

29 August 2023 in Journal of Biological Engineering
Verified
Journal Article
Open access
PDF file
WLWenqing Liang
Wenqing Liang
CZChao Zhou
Chao Zhou
HZHongwei Zhang
Hongwei Zhang
JBJuqin Bai
Juqin Bai
BJBo Jiang
Bo Jiang
JZJiayi Zhao
Jiayi Zhao
The use of biodegradable polymers for treating bone-related diseases has become a focal point in the field of biomedicine. Recent advancements in material technology have expanded the range of materials suitable for orthopaedic implants. Three-dimensional (3D) printing technology has become prevalent in healthcare, and while organ printing is still in its early stages and faces ethical and technical hurdles, 3D printing is capable of creating 3D structures that are supportive and controllable. The technique has shown promise in fields such as tissue engineering and regenerative medicine, and new innovations in cell and bio-printing and printing materials have expanded its possibilities. In clinical settings, 3D printing of biodegradable metals is mainly used in orthopedics and stomatology. 3D-printed patient-specific osteotomy instruments, orthopedic implants, and dental implants have been approved by the US FDA for clinical use. Metals are often used to provide support for hard tissue and prevent complications. Currently, 70–80% of clinically used implants are made from niobium, tantalum, nitinol, titanium alloys, cobalt-chromium alloys, and stainless steels. However, there has been increasing interest in biodegradable metals such as magnesium, calcium, zinc, and iron, with numerous recent findings. The advantages of 3D printing, such as low manufacturing costs, complex geometry capabilities, and short fabrication periods, have led to widespread adoption in academia and industry. 3D printing of metals with controllable structures represents a cutting-edge technology for developing metallic implants for biomedical applications. This review explores existing biomaterials used in 3D printing-based orthopedics as well as biodegradable metals and their applications in developing metallic medical implants and devices. The challenges and future directions of this technology are also discussed.

24 January 2019 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
MCMeikai Chen
Meikai Chen
YXYifan Xu
Yifan Xu
TZTan Zhang
Tan Zhang
YMYuliang Ma
Yuliang Ma
JLJunquan Liu
Junquan Liu
WLWenqing Liang
Wenqing Liang

9 February 2024 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
WLWenqing Liang
Wenqing Liang
CZChao Zhou
Chao Zhou
JBJuqin Bai
Juqin Bai
HZHongwei Zhang
Hongwei Zhang
BJBo Jiang
Bo Jiang
HZHaibing Zhu
Haibing Zhu
Recent advancements in orthopedic surgery have greatly improved the management of musculoskeletal disorders and injuries. This review discusses the latest therapeutic approaches that have emerged in orthopedics. We examine the use of regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP) injections, to accelerate healing and promote tissue regeneration. Additionally, we explore the application of robotic-assisted surgery, which provides greater precision and accuracy during surgical procedures. We also delve into the emergence of personalized medicine, which tailors treatments to individual patients based on their unique genetic and environmental factors. Furthermore, we discuss telemedicine and remote patient monitoring as methods for improving patient outcomes and reducing healthcare costs. Finally, we examine the growing interest in using artificial intelligence and machine learning in orthopedics, particularly in diagnosis and treatment planning. Overall, these advancements in therapeutic approaches have significantly improved patient outcomes, reduced recovery times, and enhanced the overall quality of care in orthopedic surgery.